Implant Sciences' QS-B220 Passes the Detection Portion of Checkpoint Qualification Testing
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its QS-B220 desktop explosives trace detection system has successfully completed Independent Testing and Evaluation (IT&E) by the Transportation Security Administration (TSA).
The QS-B220 passed TSA's detection portion of qualification testing for checkpoint screening and is now testing at the TSA Systems Integration Facility (TSIF).
Global 3D Sensor Market Outlook (2014-2022)
"TSA checkpoint qualification is ranked amongst the most stringent explosives trace detection qualifications around the world. Completion of this phase of the qualification process is the single greatest achievement in this Company's history," stated Glenn D. Bolduc, Implant Sciences' President and CEO. "This marks us as the only company to have ever passed IT&E for the ETD checkpoint qualification using IMS with a non-radioactive source. We are extremely proud of our team's effort, dedication, and efficient execution."
"Our Company has built a product that truly deserves to be called the new standard in trace detection," added Dr. Darryl Jones, Vice President of Sales and Marketing of Implant Sciences. "Our progress in this qualification means we are one step closer towards participating in future tenders for the Department of Homeland Security. Furthermore, it also positions us to participate in procurements and tenders globally that look to this qualification as a prerequisite."
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Implant Sciences Corp.
Feb 15 - 16, 2016 - Rome, Italy